Comparative Evaluation Of Therapeutic Efficacy And Safety Of Intranasal Fluticasone Furoate And Fluticasone Propionate In Patients Of Chronic Rhinosinusitis: A Randomized, Open Label, Parallel Group Study - nil

Govt Doon Medical college0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年4月29日

试验速览

暂无简介。

•1.Newly diagnosed cases of chronic rhinosinusitis in age group of 18-60 years .
•2. Patients giving valid informed consent.

•1. Cases having active upper air way infection, malignant / benign mass of nose and PNS and post-operative cases of functional endoscopic sinus surgery.
•2. Patient having symptomatic gross Deviated Nasal Septum(DNS),Septal perforation and/or Nasal polyps, severe epistaxis, purulent nasal infection
•3. Patients refusing to participate in the study.
•4. Dependence on prolonged corticosteroid therapy for comorbid conditions, such as asthma and chronic obstructive pulmonary disease
•5. History of allergy to fluticasone propionate or fluticasone furoate or other topical steroids.
•6. History of clinically significant cardiac, renal, psychiatric, hepatic and endocrine disease.
•7. Pregnant or breastfeeding females.
•8. Known immunodeficiency state.
•9. Patients of Fungal Rhinosinusitis.

发起方

Govt Doon Medical college